Anand Bagaria, senior research analyst, Finquest explains to CNBC-TV18 that pharma major Wockhardt has posted a strong run in terms of a stock performance as well as fundamentals and gained over 250% from the start of the year.
first published: Aug 7, 2012 03:22 pm
A collection of the most-viewed Moneycontrol videos.
Trump Claims Iran Will Never Shut Hormuz Again, Big Statement Raises Global Questions
AMIT SHAH FULL SPEECH: Amit Shah Addresses Lok Sabha on Reservation, Delimitation & Representation
Live: Broader markets outperform this week; Metal, realty top sectoral plays | Closing Bell
Trump Signals Major Breakthrough In Iran Deal, May Visit Islamabad Soon
